Magnolia Medical Technologies
PrivateLast Round
Growth Equity
Feb 16, 2022
Total Funding Raised
$116M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Magnolia Medical Technologies operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Growth Equity round in February 2022.
Magnolia Medical Technologies is a healthcare company that develops blood-collection systems designed to eliminate sepsis misdiagnosis by preventing false-positive blood culture results through a sterile, closed collection process.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magnolia Medical Technologies Comparables
Compare Magnolia Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kurin, Inc. | 93% | |
| Neomend | 74% | |
| Sarstedt AG & Co. KG | 67% |
For institutional investors. Book with your work email.
Magnolia Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Feb 16, 2022 | ||||
| Debt | May 27, 2020 | ||||
| Series C | Jan 30, 2019 | ||||
| Series B Extension | Apr 4, 2017 | ||||
| Series B | Jul 13, 2016 | ||||
Series A | Nov 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Magnolia Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Growth Equity |
| Evidity Health Capital | Growth Equity, Series C |
| SightLine Partners | Growth Equity, Series C |
| Horizon Technology Finance Corporation | Debt |
| Sectoral | Growth Equity |
| RTW Investments | Growth Equity, Series C |
| Band of Angels | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Company holds over 70 issued patents with 50+ applications pending.
- Apr 1, 2026
Steripath device receives FDA-cleared indication for reducing blood culture contamination.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 12, 2026
Magnolia Medical Technologies, Inc appoints Roma Patel as Vice President, Marketing in Washington on Nov 12th '26, where she joins the executive leadership team and leads marketing across market development, product and portfolio strategy, clinical education, and Steripath platform adoption.
For institutional investors. Book with your work email.
Magnolia Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Magnolia Medical Technologies's valuation, stock price, and market status.
Is Magnolia Medical Technologies a public or private company?
Magnolia Medical Technologies is a private company.
What is the current stock price of Magnolia Medical Technologies?
Magnolia Medical Technologies is a private company, so its shares have no public market price. Caplight tracks Magnolia Medical Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magnolia Medical Technologies worth (valuation)?
Valuation information for Magnolia Medical Technologies is not publicly available.
Can I buy Magnolia Medical Technologies stock?
Magnolia Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magnolia Medical Technologies's last funding round?
Magnolia Medical Technologies's most recent funding round was Growth Equity on February 16, 2022.
Who are the main investors in Magnolia Medical Technologies?
Key investors in Magnolia Medical Technologies include Horizon Technology Finance Corporation, Sectoral, RTW Investments, Canepa Healthcare, HealthQuest Capital.
Will Magnolia Medical Technologies IPO soon?
No public IPO plans have been announced for Magnolia Medical Technologies.
How can I track Magnolia Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Magnolia Medical Technologies's shares on secondary markets.